Posts In: Pharma cold chain

Biocon Chief Kiran Mazumdar Shaw leads investment in women’s health platform Gytree

Gytree.com announced its first round of fundraising, led by Biocon’s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma...

Continue Reading

US FDA approves Lupin for generic drugs to treat HIV infection

Lupin, a transnational pharmaceutical company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) to market its generic...

Continue Reading

Dr Reddy’s acquires trademark rights for Pfizer breast cancer drug

Dr. Reddy’s Laboratories Ltd. announced that it has acquired the trademark rights of the breast cancer drug Primcyv from Pfizer ProductsIndia Pvt Ltd for use...

Continue Reading

All about iNcovacc, the intranasal Covid-19 vaccine of Bharat Biotech

The world’s first intranasal vaccine, christened as iNcovacc, is based on a delivery vehicle, a virus, that causes the common cold (adenovirus vector). The spike...

Continue Reading

Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolio

Pharmaceutical major Cipla NSE 0.46 % announced that its wholly-owned UK subsidiary Cipla (EU) Limited has signed definitive agreements to invest 15 million euros in...

Continue Reading

Sun Pharma’s proposal to amend CT protocol for pimavanserin gets CDSCO Panel nod

Approving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...

Continue Reading

Cipla’s higher automation spends to continue for 3 more years: CTO Geena Malhotra

Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered company started its investment journey...

Continue Reading

Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine

Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization (CDSCO), in its minutes for the meeting held...

Continue Reading

Hetero’s COVID-19 oral drug Nirmacom (generic Paxlovid) gets WHO prequalification

Hetero, a city-based leading pharmaceutical company announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of...

Continue Reading